ArticleCell death & disease2022

PARP inhibitor olaparib enhances the efficacy of radiotherapy on XRCC2-deficient colorectal cancer cells.

Changjiang Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.